Rain Capital Management’s Edwards Lifesciences EW Stock Holding History

Rain Capital Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$621K	Buy	7,150 +1	+0%	+$89	0.44%	26
2024 Q1	$683K	Buy	7,149 +19	+0.3%	+$1.6K	0.46%	23
2023 Q4	$544K	Sell	7,130 -150	-2%	-$10.4K	0.38%	26
2023 Q3	$504K	Sell	7,280 -144	-2%	-$11.6K	0.49%	22
2023 Q2	$700K	Sell	7,424 -112	-1%	-$9.73K	0.55%	21
2023 Q1	$623K	Buy	7,536 +37	+0.5%	+$2.91K	0.43%	23
2022 Q4	$560K	Buy	+7,499	New	+$578K	0.42%	25

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Rain Capital Management's EW Position: Q2 2024 in Review

Rain Capital Management increased its Edwards Lifesciences (EW) stake by 0.01% in Q2 2024, buying an estimated $89 and bringing the position to 7,150 shares worth $621K. The position accounts for 0.44% of the portfolio, ranked #26.

Rain Capital Management first reported a position in EW in Q4 2022 and has held it in 7 quarters since. The position peaked at $700K in Q2 2023. 1,296 funds tracked by Wall St. Rank hold EW as of Q2 2024.

Rain Capital Management held 7,150 shares of Edwards Lifesciences worth $621K as of Q2 2024.
Rain Capital Management bought 1 Edwards Lifesciences share in Q2 2024, an estimated $89.
Edwards Lifesciences made up 0.44% of Rain Capital Management's portfolio in Q2 2024, its #26 holding.
Rain Capital Management first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 7 quarters since.
Rain Capital Management's Edwards Lifesciences position peaked at $700K in Q2 2023.
1,296 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2024.

Based on Rain Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.